← Back to searchRecruitingRecruiting
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
NCT06067295 · University of Southern California
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
PRIMARY OBJECTIVE:
I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.
OUTLINE: This is an observational study.
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.
Eligibility criteria
Inclusion Criteria:
* Men of all racial and ethnic groups 18 years of age or older
* Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
* Prior participation on clinical trials is allowed
Exclusion Criteria:
* Inability to give informed consent
* Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
Study design
Enrollment target: 300 participants
Age groups: adult, older_adult
Timeline
Starts: 2023-02-21
Estimated completion: 2027-12-31
Last updated: 2026-03-10
Interventions
Other: Non-Interventional Study
Primary outcomes
- • Collection of biological specimens and clinical data for future research related to prostate cancer. (Up to 5 years)
Sponsor
University of Southern California · other
With: National Cancer Institute (NCI)
Contacts & investigators
ContactCheryl Kefauver, RN · contact · Cheryl.Kefauver@med.usc.edu · 323-865-0459
InvestigatorAmir Goldkorn, MD · principal_investigator, University of Southern California
All locations (2)
Los Angeles General Medical CenterRecruiting
Los Angeles, California, United States
USC / Norris Comprehensive Cancer CenterRecruiting
Los Angeles, California, United States